CRISPR Therapeutics AG — Director's Dealing 2021

Mar 12, 2021

SEC Form 4/A — Form 4/A

Issuer: CRISPR Therapeutics AG (CRSP)
CIK: 0001674416
Period of Report: 2021-01-15

Reporting Person: Klein Lawrence Otto (CBO & COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-15	Common Shares	M	16334	$14.43	Acquired	26942	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	10608	Direct

Footnotes

F1: This amended Form 4 is being filed to correct the number of shares acquired on January 15, 2021.

F2: The original Form 4 filed on January 20, 2021 inadvertently included the wrong amount of shares beneficially owned after each transaction. This amended Form 4 is being filed to correct the number of shares beneficially owned following the transactions on January 15, 2021.